Meet Patel

Meet Patel

Auto-generated profile, based on publicly available information

Meet Patel

Department of Internal Medicine, Tianjin Medical University, Tianjin, 301700, P. R. China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Cureus
Verified
Journal Article
Open access
HYHarshani Yarlagadda
Harshani Yarlagadda
MPMeet A Patel
Meet A Patel
VGVasu Gupta
Vasu Gupta
TBToram Bansal
Toram Bansal
SUShubekshya Upadhyay
Shubekshya Upadhyay
RJRohit Jain
Rohit Jain
The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine.

1 May 2023 in Current Cardiology Reviews
Verified
Journal Article
Closed access
PDF file
MPMeet Patel
Meet Patel
HYHarshani Yarlagadda
Harshani Yarlagadda
SUShubekshya Upadhyay
Shubekshya Upadhyay
RNRitesh Neupane
Ritesh Neupane
UQUmer Qureshi
Umer Qureshi
RJRohit Jain
Rohit Jain
Sleep-related breathing disorders, including obstructive sleep apnea (OSA) and central sleep apnea (CSA), have a major impact on cardiovascular function. It has shown an association with hypertension, coronary artery disease, cardiac arrhythmias, sudden cardiac death, and congestive heart failure (CHF). This review focuses on highlighting the relationship between sleep apnea and CHF. We discuss the underlying pathophysiology, which involves the mechanical, neurohormonal, and inflammatory mechanisms; in addition, the similarities and differentiating clinical features of OSA in patients with CHF and without CHF. We have also discussed several treatment strategies, including weight loss, continuous positive airway pressure (CPAP), supplemental oxygen therapy, theophylline, acetazolamide, mandibular advancement device, and hypoglossal nerve stimulation (HGNS). We conclude that since there are several overlapping clinical features in patients with OSA with Heart Failure (HF) and without HF, early detection and treatment are crucial to decrease the risk of HF, coronary artery disease, and stroke.

9 September 2024 in Future Cardiology
Verified
Journal Article
Closed access
BSBhupinder Singh
Bhupinder Singh
MPMeet A Patel
Meet A Patel
SGShreya Garg
Shreya Garg
VGVasu Gupta
Vasu Gupta
ASAmishi Singla
Amishi Singla
RJRohit Jain
Rohit Jain
Congestive Heart Failure (CHF) poses significant challenges to the healthcare system due to its high rates of morbidity and mortality as well as frequent readmissions. All of these factors contribute to increased healthcare delivery costs. Besides the burden on the healthcare system, CHF has far deeper effects on the patient in terms of psychological burden along with debilitating symptoms of dyspnea, all of which reduce quality of life. Prognostic awareness among patients about their disease along with initiating early goals of care discussion by those involved in the care (physicians, nurses, social worker and patient themselves) can help mitigate these challenges. Adopting a proactive approach to address patient preferences, values and end-of-life goals improves patient-centred care, enhances quality of life and reduces the strain on healthcare resources. In this narrative review, studies have been identified using PubMed search to shed knowledge on what is preventing the initiation of goals of care discussions. Some barriers include lack of knowledge about prognosis in both patients and caregivers, inexperience or discomfort in having those conversations and delaying it until CHF becomes too advanced.

29 April 2024 in Turkish Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
VGVasu Gupta
Vasu Gupta
FAFnu Anamika
Fnu Anamika
KPKinna Parikh
Kinna Parikh
MPMeet A Patel
Meet A Patel
RJRahul Jain
Rahul Jain
RJRohit Jain
Rohit Jain
Artificial intelligence (AI), with its infinite capabilities, has ushered in an era of transformation in the twenty-first century. ChatGPT (Generative Pre-trained Transformer), an AI language model, has lately been in the spotlight, and there is an increasing partnership between the research authors and the chatGPT. Using ChatGPT, authors can set new benchmarks in paper writing in terms of speed, accuracy, consistency, and adaptability. ChatGPT has turned out to be an invaluable tool for manuscript writing, editing, and reference management. While it has numerous advantages, it has been criticised due to ethical quandaries, inaccuracies in scientific data and facts, and, most importantly, a lack of critical thinking skills. These disadvantages of using ChatGPT place limitations on its use in medical publications since these articles guide the future management of many diseases. While AI can fix issues, it lacks the ability to think like humans and thus cannot substitute human authors. To better comprehend the future of this technology in research, we discuss the advantages, drawbacks, and ethical dilemmas of using ChatGPT in paper writing by reviewing existing literature on Pubmed and Google Scholar and using ChatGPT itself to understand the prompt response.